Contact us : info@bioworlde.com
Home > Product > Antigen-Peptide
p-Synaptotagmin 1/2 (T202/199) Peptide BS4191P
Product Namep-Synaptotagmin 1/2 (T202/199) Peptide
Catalog No.BS4191P
ApplicationsBlocking
Swiss-ProtP21579/Q8N9I0
Product1 mg/ml in DI water.
Purification&PuritySynthetic peptide p-Synaptotagmin 1/2 (T202/199). (Note: the amino acid sequence is proprietary). The purity is > 98%.
Storage&StabilityStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
SpecificityThis peptide can be used with studies using BS4191 p-Synaptotagmin 1/2 (T202/199) pAb.
Browse similar products>>
Size Price
1mg $368
Add to cart My orders
Product Name :
p-Synaptotagmin 1/2 (T202/199) Peptide
Applications :
Blocking
Background :
Synaptotagmins are a large gene family of synaptic vesicle type III integral membrane proteins that function as regulators of both exocytosis and endocytosis and are involved in neurotransmitter secretion from small secretory vesicles. Calcium binds to Synaptotagmin I which triggers neurotransmitter release at the synapse. Synaptotagmin II is phosphorylated by WNK1 in a process that regulates calcium-dependent interactions. Synaptotagmin III is involved in calcium-dependent exocytosis of secretory vesicles in endocrine cells and neurons. Synaptotagmin IV is expressed in neuronal tissues, and has the highest mRNA levels in the hippocampus.
Alternative Name :
synaptotagmin 1; synaptotagmin 2; Synaptotagmin I; Synaptotagmin II; SYT; SYT1; SYT2; SytI; SytII;
Swiss-Prot :
P21579/Q8N9I0
Product :
1 mg/ml in DI water.
Purification&Purity :
Synthetic peptide p-Synaptotagmin 1/2 (T202/199). (Note: the amino acid sequence is proprietary). The purity is > 98%.
Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity :
This peptide can be used with studies using BS4191 p-Synaptotagmin 1/2 (T202/199) pAb.
Blocking peptide available as BS4191PP
COPYRIGHT © 2015-2018 Bioworld Technology, Inc. All rights reserved POLYCLONAL AND MONOCLONAL ANTIBODY CENTER